West Pharmaceutical Services (WST) Receivables - Other (2017 - 2025)
Historic Receivables - Other for West Pharmaceutical Services (WST) over the last 9 years, with Q4 2025 value amounting to $11.9 million.
- West Pharmaceutical Services' Receivables - Other fell 4892.7% to $11.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.9 million, marking a year-over-year decrease of 4892.7%. This contributed to the annual value of $11.9 million for FY2025, which is 4892.7% down from last year.
- As of Q4 2025, West Pharmaceutical Services' Receivables - Other stood at $11.9 million, which was down 4892.7% from $27.5 million recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Receivables - Other registered a high of $42.3 million during Q3 2024, and its lowest value of $10.1 million during Q2 2021.
- Its 5-year average for Receivables - Other is $19.9 million, with a median of $19.6 million in 2023.
- Its Receivables - Other has fluctuated over the past 5 years, first surged by 11256.28% in 2024, then crashed by 4892.7% in 2025.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Receivables - Other stood at $14.6 million in 2021, then rose by 11.64% to $16.3 million in 2022, then skyrocketed by 31.9% to $21.5 million in 2023, then rose by 8.37% to $23.3 million in 2024, then tumbled by 48.93% to $11.9 million in 2025.
- Its Receivables - Other was $11.9 million in Q4 2025, compared to $27.5 million in Q3 2025 and $27.9 million in Q2 2025.